Grannus Therapeutics Named 2025 MIRA Awards Finalist

BioCrossroads Life Sciences Innovation Team Award

Awards
December 5, 2024
Grannus Therapeutics Named 2025 MIRA Awards Finalist

Grannus Therapeutics Named 2025 MIRA Awards Finalist

We are pleased to share Grannus Therapeutics was named a finalist in the 2025 Mira Awards in the BioCrossroads Life Sciences Innovation Team category. We’re honored to be recognized for our mission to transform cancer care by this prestigious group.

Now in its 26th year, TechPoint’s Mira Awards are designed to elevate the most innovative companies in Indiana’s tech ecosystem. The BioCrossroads Life Sciences Innovation Team of the Year Award celebrates exceptional innovations in the life sciences sector, honoring teams that have made groundbreaking advancements in research, development and application to ultimately benefit patients.

As we continue to grow our platform and pipeline, it’s incredibly rewarding to see our work acknowledged alongside other top innovators across Indiana. Congratulations to all the finalists, and thank you to TechPoint for creating a platform that brings the innovation community together to celebrate Indiana’s leadership in health, biotechnology, medical devices and pharmaceutical innovation.

Read Full Article